首页> 外文期刊>Central European Journal of Urology: The Polish Journal of Urology >Comparative efficacy of tadalafil versus tamsulosin as the medical expulsive therapy in lower ureteric stone: a prospective randomized trial
【24h】

Comparative efficacy of tadalafil versus tamsulosin as the medical expulsive therapy in lower ureteric stone: a prospective randomized trial

机译:他达拉非与坦索罗辛在下输尿管结石中作为药物排除疗法的比较疗效:一项前瞻性随机试验

获取原文
       

摘要

Introduction In recent years, medical expulsive therapy has been used in the management of distal ureteric stones as a supplement to conservative treatment. Therefore, we conducted a prospectiverandomized study to evaluate the possible role of tadalafil individually in comparison with proven tamsulosin therapy in ureteric stone expulsion.The aim of this study is to compare the safety and efficacy of a phosphodiesterase-5 inhibitor (tadalafil) and an α-1 blocker (tamsulosin) as medical expulsive therapy for distal ureteric calculi.Material and methods Between August 2014 and October 2015, 207 patients who presented with distal ureteric stones of size 5–10 mm were randomly divided into two groups: tadalafil (Group A) and tamsulosin (Group B). Therapy was given for a maximum of 4 weeks. Stone expulsion rate, time to stone expulsion, analgesic use, number of hospital visits for pain, follow-up, endoscopic treatment and adverse effectsof drugs were noted. Both groups were compared for normally distributed data by percentage, analysisof variance, and T-test. All the classified and categorical data were analyzed for both groups using thechi-square test.Results A statistically significant expulsion rate of 84.0% in Group A compared with 68.0% in Group B(P value = 0.0130), and shorter stone expulsion time in Group A (14.7±3.8) in comparison to Group B (16.8 ±4.5) was observed. Statistically significant differences were noted in renal colic episodes and analgesic requirement in Group A than Group B. No serious adverse effects were noted.Conclusions Tadalafil is safe, efficacious, and well tolerated as medical expulsive therapy for distalureteric stones. This study showed that tadalafil increases ureteric stone expulsion quite significantly along with better control of pain and significantly lower analgesic requirement.
机译:引言近年来,药物排斥疗法已用于远端输尿管结石的治疗,作为保守治疗的补充。因此,我们进行了一项前瞻性随机研究,以评估他达拉非与经证实的坦索罗辛治疗在输尿管结石排出中的可能作用。本研究的目的是比较磷酸二酯酶5抑制剂(他达拉非)和α的安全性和有效性。 -1受体阻滞剂(坦索罗辛)作为输尿管远端结石的药物治疗方法。材料与方法2014年8月至2015年10月,将207例出现5-10 mm远端输尿管结石的患者随机分为两组:他达拉非(A组) )和坦洛新(B组)。治疗最长为4周。记录了石块排出率,石块排出时间,止痛药的使用,疼痛的就诊次数,随访,内窥镜治疗和药物的不良反应。通过百分比,方差分析和T检验比较两组的正态分布数据。结果使用卡方检验分析两组的所有分类和分类数据。结果A组的驱逐率具有统计学显着性,B组为68.0%(P值= 0.0130),A组的驱逐时间较短。与B组(16.8±4.5)相比,观察到A(14.7±3.8)。 A组的肾绞痛发作和镇痛要求与B组相比在统计学上有显着差异。未观察到严重的不良反应。结论Tadalafil作为输尿管远端结石的药物排斥疗法安全,有效且耐受性良好。这项研究表明,他达拉非可以显着提高输尿管结石的排出,同时可以更好地控制疼痛并显着降低镇痛要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号